Molecure S.A.

Informe acción WSE:MOC

Capitalización de mercado: zł173.4m

Molecure Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Marcin Szumowski

Chief Executive Officer (CEO)

zł473.2k

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO0.7%
Permanencia media de la dirección3.8yrs
Promedio de permanencia en la Junta Directiva2.8yrs

Actualizaciones recientes de la dirección

Recent updates

Is Molecure (WSE:MOC) In A Good Position To Deliver On Growth Plans?

Aug 20
Is Molecure (WSE:MOC) In A Good Position To Deliver On Growth Plans?

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Apr 20
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Dec 01
We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Jul 07
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Mar 10
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Aug 16
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Nov 04
OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Feb 24
Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

Jan 02
Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

CEO

Marcin Szumowski

no data

Permanencia

zł473,205

Compensación

Dr. Marcin Jan Szumowski, Ph D., is employed at Life Science Innovations Fund. He has been Chief Executive Officer and President of the Management Board at Molecure S.A. (formerly known as OncoArendi Thera...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Marcin Szumowski
Co-Founderno datazł473.21k0.70%
PLN 1.2m
Slawomir Broniarek
CFO & Member of the Management Boardno datazł421.09k0.20%
PLN 355.4k
Zbigniew Zaslona
Chief Scientific Officer & Member of Management Board2.8yrszł473.21k0.11%
PLN 194.6k
Agnieszka Rajczuk-Szczepanska
Member of Management Board & HR Director4.8yrszł348.41k0.034%
PLN 59.7k
Adam Golebiowski
Co-Founder & VP of Research Chemistry12.8yrszł500.00k3.01%
PLN 5.2m
Jacek Olczak
Co-Founder & Head of Medicinal Chemistryno datasin datossin datos
Piotr Iwanowski
Chief Medical Officer & Member of Management Boardless than a yearsin datossin datos
Magdalena Tyszkiewicz
Head of CMC4.8yrssin datossin datos
Marta Borkowska
Director of the Management Board Office2.8yrssin datossin datos

3.8yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de MOC se considera experimentado (3.8 años antigüedad media).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Luke O'Neill
Member of Scientific Advisory Boardno datasin datossin datos
Bart Lambrecht
Member of Scientific Advisory Boardno datasin datossin datos
Tomasz Piec
Vice Chairman of the Supervisory Board4.8yrszł133.62ksin datos
Douglas Hay
Member of Scientific Advisory Boardno datasin datossin datos
Paul Van Der Horst
Independent Chairman of the Supervisory Board2.8yrszł132.99k0.059%
PLN 103.0k
Nancy Van Osselaer
Independent Member of the Supervisory Board2.8yrszł124.22ksin datos
Agnieszka Motyl
Member of the Supervisory Board1.3yrszł44.45ksin datos
Pawel Trawkowski
Independent Member of the Supervisory Board2.4yrszł124.22ksin datos

2.8yrs

Permanencia media

Junta con experiencia: La junta directiva de MOC no se considera experimentada (2.8 años de permanencia promedio), lo que sugiere una nueva junta directiva.